Dr. David L Deaver Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 3210 Churchland Blvd, Suite 4, Chesapeake, VA 23321 Phone: 757-483-3340 Fax: 757-483-0461 |
Dr. Barbara Rivera Haskins, PSYD Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 2006 Old Greenbrier Rd, Suite 5, Chesapeake, VA 23320 Phone: 757-961-0567 |
Coleen Lively, MA Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 2107 Liberty St, Chesapeake, VA 23324 Phone: 757-494-7600 |
Dr. Stephen Carl Ganderson, PSY.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 505 Cedar Rd, Suite B-1, Chesapeake, VA 23322 Phone: 757-548-9996 Fax: 757-382-5085 |
Dr. Robin Duers Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 816 Greenbrier Cir Ste 209, Chesapeake, VA 23320 Phone: 757-402-0258 |
Mrs. Karen Gardiner Psychologist - Mental Retardation & Developmental Disabilities Medicare: Not Enrolled in Medicare Practice Location: 1304 Links Ct, Chesapeake, VA 23320 Phone: 757-292-7612 Fax: 757-548-6003 |
Dr. Randy A. Rhoad, PSY.D. Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 1435 Crossways Blvd, Suite 109, Chesapeake, VA 23320 Phone: 757-410-0072 Fax: 757-410-7290 |
Dr. Carson Fuhrman, PSY.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 1210 Progressive Dr Ste 101, Chesapeake, VA 23320 Phone: 757-420-0530 |
Mrs. Brianna Ratliff Cancian, PH. D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1403 Greenbrier Pkwy, Suite 215, Chesapeake, VA 23320 Phone: 757-410-0700 |
Dr. Gregory Lee Asgaard, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 105 Gateway Ct, Apt. # 209, Chesapeake, VA 23320 Phone: 618-203-1050 |
Dr. Andrew Franklin, PHD Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 2006 Old Greenbrier Rd, Chesapeake, VA 23320 Phone: 757-337-1296 |
News Archive
Neuraltus Pharmaceuticals, a privately held biopharmaceutical company dedicated to developing and commercializing high-impact therapeutics that address critical unmet medical needs, primarily for the treatment of neurodegenerative diseases, announced today top-line results from the Company's Phase 1 clinical study of NP001 for the treatment of Amyotrophic Lateral Sclerosis (ALS, or Lou Gehrig's disease).
As the COVID-19 pandemic continues to claim lives throughout the world, the evidence is mounting that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) affects the respiratory tract as well as the central nervous system. Now, a new study by German researchers published on the preprint server bioRxiv in June 2020 describes various neurological manifestations of COVID-19, as well as the underlying pathophysiology.
For many patients with difficult-to-treat neuropathic pain, deep brain stimulation (DBS) can lead to long-term improvement in pain scores and other outcomes, according to a study in the February issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.
GE Healthcare officials today received a very special American flag from Lieutenant General Jack C. Stultz, Chief of the Army Reserve and Commanding General of the U.S. Army Reserve Command, this Tuesday during Memorial Day observances at the company's Healthcare Institute in Waukesha.
› Verified 6 days ago